Literature DB >> 21182715

Food safety and products from aquaculture.

A Reilly1, F Käferstein.   

Abstract

Aquaculture is currently one of the fastest growing food production systems in the world with production increasing at an average rate of 9.6% per year over the past decade. As world fish stocks are reaching the limits of exploitation, we shall rely to a far greater extent on products from aquaculture as food sources of high nutritional value. Approximately 90% of global aquaculture production is based in Asia, where it provides an important source of dietary animal protein of the region and income for millions of small-scale farmers. Commercial aquaculture contributes significantly to the economies of many producing countries, where highly valued species are a major source of foreign. Many different aquaculture systems exist world wide, ranging from small family-sized fish ponds to intensive cage culture industries as used in salmon fishing. There has been an expansion in the use of integrated farming systems, especially in Asia, where animal and human faeces are used to fertilise ponds. This paper will review global aquaculture systems used in the production of finfish and crustaceans and will focus on potential hazards arising from biological contamination of products that pose risks to public health. 1998 Society of Applied Microbiology.

Entities:  

Mesh:

Year:  1998        PMID: 21182715     DOI: 10.1111/j.1365-2672.1998.tb05305.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  3 in total

1.  Fish processing and human infection.

Authors:  Nevio Cimolai
Journal:  CMAJ       Date:  2017-11-13       Impact factor: 8.262

Review 2.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

Review 3.  [Public health issues associated with seafood consumption].

Authors:  C Lupo; J-L Angot
Journal:  Bull Acad Natl Med       Date:  2020-10-16       Impact factor: 0.144

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.